Boehringer Ingelheim has acquired University of Basel spinout T3 Pharmaceuticals for 450 million CHF ($507.4 million) in an effort to expand its immuno-oncology portfolio with T3’s platform. The …
Read Full Story at source (may require registration)
The latest data release from the Commodity Futures Trading Commission (CFTC) reveals a marginal improvement…
Traders and economists are taking a keen interest in the latest update from the Commodity…
In an updated report dated April 18, 2025, the Commodity Futures Trading Commission (CFTC) has…
The Commodity Futures Trading Commission (CFTC) has reported an improvement in wheat speculative net positions…
In its latest release, the U.S. Commodity Futures Trading Commission (CFTC) reported a decrease in…
Amid market turmoil, will Bitcoin keep going up or is it due for another correction?…
This website uses cookies.